Shih-Shih Chen
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 3
- Hematology top 5%
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Immunology top 10%
-
- PI3K/AKT/mTOR signaling in cancer 1
-
- Advanced Breast Cancer Therapies 1
-
- Adipokines, Inflammation, and Metabolic Diseases 1
-
- CAR-T cell therapy research 1
- Co-authors
- Nicholas ChiorazziMichael J. KeatingJan A. BurgerJoseph J. BuggyKumudha BalakrishnanVarsha GandhiSusan O’BrienSabine Ponader
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Shih-Shih Chen
10 papers receiving 837 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Genetics 530
- Pathology and Forensic Medicine 350
- Hematology 189
- Immunology 247
- Cancer Research 88
Countries citing papers authored by Shih-Shih Chen
This map shows the geographic impact of Shih-Shih Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih-Shih Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih-Shih Chen more than expected).
Fields of papers citing papers by Shih-Shih Chen
This network shows the impact of papers produced by Shih-Shih Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih-Shih Chen. The network helps show where Shih-Shih Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shih-Shih Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 9 | |
| 4 | 2018 | 16 | |
| 5 | 2016 | 13 | |
| 6 | The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivobreakdown → | 2011 | 499 |
| 7 | 2010 | 57 | |
| 8 | 2009 | 21 | |
| 9 | 2008 | 114 | |
| 10 | 2006 | 100 | |
| 11 | 2003 | 20 |
About Shih-Shih Chen
Shih-Shih Chen is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 11 papers that have together received 850 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper), Advanced Breast Cancer Therapies (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Genetics (530 citations), Pathology and Forensic Medicine (350 citations) and Hematology (189 citations). Shih-Shih Chen has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Nicholas Chiorazzi, Michael J. Keating, Jan A. Burger, Joseph J. Buggy, Kumudha Balakrishnan, Varsha Gandhi, Susan O’Brien, Sabine Ponader, William G. Wierda and Christoph Plass. Their work appears in journals such as Blood, Cancer Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.